APS (Acta Pharmacologica Sinica)

  • APS (Acta Pharmacologica Sinica)  image
  • http://www.nature.com/aps
  • Editor: Jian Ding
  • Volume 30: 12 issues per year
  • ISSN: 1671-4083
  • EISSN: 1745-7254
  • Impact factor : 1.677*
  • Impact ranking: 40/127 Multidisciplinary Chemistry*, 129/205 Pharmacology and Pharmacy*
  • Date Established: 1980
  • Published on behalf of: the Shanghai Institute of Materia Medica at the Chinese Academy of Sciences

Aims and Scope: APS (Acta Pharmacologica Sinica) is an international peer-reviewed journal. APS encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to:

  • Anticancer pharmacology
  • Cardiovascular and pulmonary pharmacology
  • Molecular and cellular pharmacology
  • Neuropharmacology
  • Pharmaceutics
  • Pharmacokinetics
  • Clinical pharmacology
  • Gastrointestinal and hepatic pharmacology
  • Drug discovery
  • Genitourinary, renal and endocrine pharmacology
  • Immunopharmacology and inflammation

Readership: APS appeals to academic, industry and health services pharmacologists and drug scientists.

Online features and site license access:

  • Online archive from January 2005 to current issue will be available on www.nature.com in 2009. Online archive from 1980 to 2004 will be available on www.chinaphar.com in 2009.
  • A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period. Archive content is freely available after 5 years.
  • Users benefit from all the online features outlined on pages 6-9.
  • Indexed in: BIOSIS, CA, CSA Medical Biotechnology, CSA Bioengineering, CSA Neuroscience, Current Contents/Life Sciences, Excerpta Medica, FSTA, Global Health, IndexCopernicus, Index Medicus, Kagaku Gijutsu Bunken Sokuho (Japan), MEDLINE, Реѿеѿаѿнвнѿй жѿѿнал (Russia), Research Alert, Science Citation Index, SciSearch, Scopus, and Tropical Diseases Bulletin.

*2007 Journal Citation Report (Thomson Reuters, 2008)

Extra navigation

ADVERTISEMENT